Aldevron recently announced its upcoming virtual ribbon cutting event, which will take place on Wednesday, February 10 at 12:00 PM CST. Its focus will be the company's investments in key areas, expanding Aldevron's ability to enable clients' breakthroughs in the emerging field of genetic medicine, further impacting patients and achieving the company's mission.
The lineup of speakers features Matthew Porteus, MD, PhD, who will be sharing a technical keynote on his groundbreaking work on Sickle Cell Disease.